Provided by Tiger Trade Technology Pte. Ltd.

YieldMax HIMS Option Income Strategy ETF

12.25
+0.30042.51%
Post-market: 12.250.00000.00%19:59 EDT
Volume:46.01K
Turnover:558.05K
Market Cap:12.25M
PE:- -
High:12.31
Open:11.99
Low:11.94
Close:11.95
52wk High:53.97
52wk Low:9.53
Shares:1.00M
Float Shares:1.00M
Volume Ratio:0.79
T/O Rate:4.60%
Dividend:16.45
Dividend Rate:134.26%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

BofA Adjusts Price Target on Hims & Hers Health to $25 From $28

MT Newswires Live
·
May 26

Hims & Hers : Bofa Global Research Cuts Price Objective to $25.00 From $28.00

THOMSON REUTERS
·
May 26

Does Medicine's New Obsession Really Work? -- Barron's

Dow Jones
·
May 23

Hims & Hers Health Is Maintained at Hold by Truist Securities

Dow Jones
·
May 22

Truist Adjusts Price Target on Hims & Hers Health to $23 From $18, Maintains Hold Rating

MT Newswires Live
·
May 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)

TIPRANKS
·
May 22

YieldMax HIMS ETF Declares Weekly Dividend of $0.2186 Per Share

Deep News
·
May 22

Moderately bullish activity in Hims and Hers Health with shares up 3.78%

TIPRANKS
·
May 22

Sector Update: Healthcare Stocks Rise Thursday Afternoon

MT Newswires Live
·
May 22

Hims & Hers Health to Sell Generic GLP-1 Drugs in Canada

Dow Jones
·
May 21

Hims & Hers launches generic semaglutide access in Canada from CAD 149/month

Reuters
·
May 21

Hims & Hers: Introduces Access to Generic Semaglutide for Canadian Customers

THOMSON REUTERS
·
May 21

CORRECTED-Hims offers Apotex's generic semaglutide in Canada after Novo patent expiry

Reuters
·
May 21

Hims & Hers: IF Prescribed by a Licensed Healthcare Provider, Personalized Treatment Plans Start at C$149/Mo

THOMSON REUTERS
·
May 21

Live Longer and Better. Does Medicine's New Obsession Really Work? -- Barrons.com

Dow Jones
·
May 21

Analysts’ Top Healthcare Picks: Hims & Hers Health (HIMS), SAB Biotherapeutics (SABS)

TIPRANKS
·
May 20

Hims CFO Oluyemi Okupe sells 7,950 shares for $187,914.74

Reuters
·
May 20

Hims & Hers Health Is Maintained at Neutral by B of A Securities

Dow Jones
·
May 20

BUZZ-U.S. STOCKS ON THE MOVE- Hims & Hers Health, Driven Brands, Onto Innovation

Reuters
·
May 20

BUZZ-U.S. STOCKS ON THE MOVE-T1 Energy, Home Depot, X-Energy

Reuters
·
May 19